Geoscience in a changed and changing world
Scienmag
MARCH 14, 2022
USA: The 2022 Geological Society of America Northeastern Section Meeting will be held in Lancaster, Pennsylvania, on 20–22 March. Boulder, Colo.,
section climate 
66 
Pfizer Announces Commitment to Accelerate Climate Action and Achieve Net-Zero Standard by 2040
Pfizer
JUNE 30, 2022
Pfizer Announces Commitment to Accelerate Climate Action and Achieve Net-Zero Standard by 2040. Pfizer Announces Commitment to Accelerate Climate Action and Achieve Net-Zero Standard by 2040. Department of Health & Human Services (HHS) pledge committing to reduce Greenhouse Gas (GHG) emissions and accelerate climate action .
Join 32,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Leading Countries in Plant-Based Meat and Dairy Innovations
XTalks
MARCH 18, 2021
While some common purchase drivers for plant-based meat and dairy among European consumers were health benefits, a curiosity to try new products and taste, an overarching driver is an awareness of climate change. Thus, European countries tend to lead the way in plant-based innovation because of their heightened awareness of climate change.
Does the Drug Shortage White Paper Fall Short?
FDA Law Blog
APRIL 8, 2024
Putting aside the question of whether the implementation of any program that requires Congressional action is feasible in the current political climate, we think the underlying premise of the White Paper falls short in both scope and in its description of factors that contribute to drug shortages. In Section I.A, Section I.C
Garden Gourmet’s Plant-Based Tuna Exploits Market ‘White Space’
XTalks
AUGUST 27, 2020
This includes pea protein, which is one of the most environmentally friendly sources of plant-based protein because peas require little land and water and can be grown in cold climates. Approximately 91 percent of plant-based seafood dollar sales are from the frozen section. Plant-based tuna used as an add-on in a salad.
JPM2023: Breakthroughs await, but so do roadblocks
pharmaphorum
JANUARY 13, 2023
But that was the tension at JPM 2023 – a tension between the incredible potential and possibility of new treatment modalities, technologies, and processes, and the incredibly daunting challenge of realising that potential amidst a cooling funding climate, regulatory and payment uncertainty, workforce instability, manufacturing challenges, and more.
Sage Therapeutics and Biogen Initiate Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for Zuranolone for the Potential Treatment of Major Depressive Disorder (MDD)
The Pharma Data
MAY 2, 2022
The rolling submission process allows completed sections of an NDA to be submitted to the FDA for review on an ongoing basis. In 2020, Biogen launched a bold 20-year, $250 million initiative to address the deeply interrelated issues of climate, health, and equity.
Let's personalize your content